InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,133.75
(
1.37%
)
US TECH 100
17,436.80
(
2.11%
)
Dow Jones
38,718.35
(
1.29%
)
Brent Oil
83.04
(
-0.71%
)
Bitcoin
61,794.75
(
4.52%
)
Post# of 146201
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

BonelessCat

Send PM Follow Ignore
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

BonelessCat

Re: drkazmd65 post# 117567

Friday, 02/05/2016 2:46:14 PM

Friday, February 05, 2016 2:46:14 PM

Post# of 146201
They haven't yet developed anything of the kind, if it is based on their Dengue and Chikungunya vaccines, vaccines unable to exit clinical testing. Most optimistically, their Zika vaccine is still a year to 2 years out once they finish preclinical work.

Promising Dengue vaccines have been in development for 25 years and the most promising have failed to exit Phase 3. The reasons are not tox but rather (1) a failure to achieve a response and protection in sufficient numbers of those vaccinated and (2) reversion to wild virus (a percentage of those vaccinated get Dengue from the inoculation) in attenuated live virus type vaccines which are the most effective against Dengue.

These are tough viruses.

They serve beer Popsicles?

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NNVC News
More NNVC News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!